Leah Sibener

Company: 3T Biosciences

Job title: Co-Founder, Head of Therapeutic Discovery

Seminars:

Workshop F: Supercharging Development of Innovative Platforms for Identification & Validation of Novel Targets Beyond CD19 3:00 pm

Identifying novel targets with potential to develop next generation CAR-TCR therapies with reduced toxic effects of on-target off-tumour reactivity Innovative preclinical and clinical trial designs to maximise patient success Exploring new ways to model tumour burden to gain a realistic representation of translation in humans Validating preclinical models and interpreting data from these models correctlyRead more

day: Workshop – Track B – Evening